Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The co-circulation of different emerging viral diseases is a big challenge from an epidemiological point of view. The similarity of symptoms, cases of virus co-infection, and cross-reaction can mislead in the diagnosis of the disease. In this article, a new mathematical model for COVID-19, zika, chikungunya, and dengue co-dynamics is developed and studied to assess the impact of COVID-19 on zika, dengue, and chikungunya dynamics and vice-versa. The local and global stability analyses are carried out. The model is shown to undergo a backward bifurcation under a certain condition. Global sensitivity analysis is also performed on the parameters of the model to determine the most dominant parameters. If the zika-related reproduction number is used as the response function, then important parameters are: the effective contact rate for vector-to-human transmission of zika ( , which is positively correlated), the human natural death rate ( , positively correlated), and the vector recruitment rate ( , also positively correlated). In addition, using the class of individuals co-infected with COVID-19 and zika ( ) as response function, the most dominant parameters are: the effective contact rate for COVID-19 transmission ( , positively correlated), the effective contact rate for vector-to-human transmission of zika ( , positively correlated). To control the co-circulation of all the diseases adequately under an endemic setting, time dependent controls in the form of COVID-19, zika, dengue, and chikungunya preventions are incorporated into the model and analyzed using the Pontryagin's principle. The model is fitted to real COVID-19, zika, dengue, and chikungunya datasets for Espirito Santo (a city with the co-circulation of all the diseases), in Brazil and projections made for the cumulative cases of each of the diseases. Through simulations, it is shown that COVID-19 prevention could greatly reduce the burden of co-infections with zika, dengue, and chikungunya. The negative impact of the COVID-19 pandemic on the control of the arbovirus diseases is also highlighted. Furthermore, it is observed that prevention controls for zika, dengue, and chikungunya can significantly reduce the burden of co-infections with COVID-19.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538730PMC
http://dx.doi.org/10.1002/oca.2936DOI Listing

Publication Analysis

Top Keywords

covid-19 zika
24
zika dengue
24
dengue chikungunya
24
positively correlated
20
effective contact
12
contact rate
12
covid-19
10
zika
10
model covid-19
8
impact covid-19
8

Similar Publications

Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines.

Mol Ther Nucleic Acids

September 2025

Viral Immunology Group, Discipline of Surgery, The Basil Hetzel Institute for Translational Health Research, The University of Adelaide, Adelaide, SA 5011, Australia.

The coronavirus disease 2019 pandemic has highlighted the critical need for thermostable vaccines to ensure equitable distribution and accessibility, particularly in regions lacking cold chain infrastructure. Here we present a thermostable, solid dose DNA vaccine (SDV) platform for subcutaneous delivery, based on a sugar-sugar alcohol-polymer formulation manufactured via lyophilization and compaction. Using luciferase-expressing plasmid as a model, we demonstrate that subcutaneous vaccination with SDV formulation of C57BL/6 mice results in efficient and durable transgene expression .

View Article and Find Full Text PDF

Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic virus that antagonizes innate immune responses, including the protein kinase R (PKR) pathway. Here, we examine the process of PKR activation in response to an immunostimulatory MERS-CoV mutant encoding an inactive endoribonuclease U and a deletion of accessory protein NS4a. We show that PKR condenses and activates on viral dsRNA proximal to viral double-membrane vesicles (DMVs).

View Article and Find Full Text PDF

Harbingers of infectious viral pandemics, such as the H1N1 influenza, SARS, Zika, Ebola, MERS, and SARS-CoV-2, caused major outbreaks in the first two decades of the 21st century. Despite warnings, therapeutic tools that could be rapidly and sustainably scaled at a global level when SARS-CoV-2 emerged were lacking. Small-molecule antivirals can play a crucial role in both individual patient care and broader public health strategies for controlling and mitigating the impact of viral diseases.

View Article and Find Full Text PDF

Pathogenic breaches: how viruses compromise blood-tissue barriers.

Tissue Barriers

August 2025

Molecular Biology Unit, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Blood-tissue barriers (BTBs) are highly specialized, selectively permeable surfaces that separate the circulatory system from delicate tissues and organs. Critical examples include the blood-brain barrier (BBB), blood-retinal barrier (BRB), blood-testis barrier (BTB), and other organ-specific barriers, including the alveolar-capillary interface in the lungs and the glomerular filtration barrier in the kidneys. These barriers regulate the bidirectional transport of nutrients, gases, and waste while restricting pathogens, toxins, and immune cells to maintain physiological balance.

View Article and Find Full Text PDF